Brain Imaging Reveals Distinct Migraine Subtypes

What Did Brain Imaging Reveal About Migraine Subtypes?

Researchers using high-resolution MRI and functional brain imaging have documented that patients describing their migraines as a 'brain on fire' or like 'an ice pick through the head' are not simply using different metaphors for the same condition. The scans reveal measurable differences in cortical thickness, white matter integrity, and activity within pain-processing networks including the thalamus, brainstem, and somatosensory cortex.

Migraine with aura, which involves visual or sensory disturbances before headache onset, shows altered activity in the occipital cortex consistent with cortical spreading depression — a wave of electrical activity that moves across the brain surface. Migraine without aura tends to involve different hypothalamic and brainstem signatures, while chronic migraine, defined as 15 or more headache days per month, shows accumulated structural changes that may reflect long-term sensitization of pain pathways.

How Could Imaging-Based Subtypes Change Migraine Treatment?

Current migraine treatment often involves cycling through preventive medications — beta-blockers, antiepileptics, antidepressants, CGRP-targeted monoclonal antibodies, and gepants — until one works. This trial-and-error approach can take months and leaves many patients undertreated. Subtype classification based on imaging biomarkers could help clinicians predict which patients are likely to respond to CGRP inhibitors versus older preventives, or which would benefit from neuromodulation devices.

The American Headache Society and International Headache Society have emphasized that biomarker-driven precision medicine is a key research priority. Imaging-based subtyping also has implications for clinical trials, allowing researchers to enroll more homogeneous patient populations and detect treatment effects that are currently obscured when diverse migraine types are pooled together.

Why Is Migraine So Often Misunderstood and Undertreated?

Despite ranking as one of the leading causes of disability worldwide for people under 50 according to the Global Burden of Disease Study, migraine remains stigmatized and underfunded relative to its public health impact. The World Health Organization classifies severe migraine attacks as among the most disabling illnesses, comparable to dementia, quadriplegia, and active psychosis during the attack itself.

The new imaging evidence reinforces what neurologists have argued for decades: migraine involves widespread brain network dysfunction, not just blood vessel changes or muscle tension. Visible biological signatures may help reduce stigma, support disability claims, and justify access to newer, more expensive targeted therapies that insurers sometimes restrict.